Summary
Overview
Work History
Education
Skills
Awards
Timeline
Generic

Lauren Becnel PhD

Seattle area,WA

Summary

Healthcare, Real-World Evidence & Data-driven Research Executive >20 years’ healthcare, real-world evidence science, genomics, & commercial excellence A seasoned leader, located in the Seattle area, with a track record of establishing then realizing long-term vision through innovative, high-impact projects. My experience and professional network range from pharma to healthcare systems, regulatory bodies, and academic researchers. I rapidly & effectively apply domain (e.g., clinical pathways, health equity, therapeutics and product development), collaborative and business knowledge to new environments to improve patient outcomes. With a passion for mentorship and personnel development, I build and inspire high-performing, interdisciplinary teams who successfully collaborate cross-functionally to surpass expected outcomes. My teams have co-created enduring solutions that drive bold state changes, help medicine and product teams deliver on business needs, and increase provider, patient and public trust in real-world evidence. Knowledgeable [Desired Position] with proven background in founding and leading successful ventures. Demonstrated ability to innovate and drive business growth through strategic planning and effective execution. Leveraged entrepreneurial mindset and leadership skills to build cohesive teams and navigate dynamic market challenges. Professional with extensive experience in founding and managing businesses, demonstrating exceptional leadership and strategic planning capabilities. Proven track record in creating and implementing effective business strategies, fostering team collaboration, and driving growth. Known for adaptability and results-focused approach, excelling in dynamic and fast-paced environments. Self-motivated professional successful in seizing viable opportunities for expansion and innovation in business. Background in increasing profits, reducing costs, and transforming customer service standards. Experienced in leading and supervising operational and sales teams. Entrepreneurial and creative Founder passionate about turning innovative ideas into tangible results. Experienced formulating and executing strategic plans, creating new products and services, and developing business opportunities. Track record of multiple successful business ventures and leading teams of professionals to maximize profits and deliver success. Pragmatic professional with solid experience in leadership roles. Adept at implementing strategic business plans, driving growth and improving operations. Skilled in financial management and stakeholder relations. Collaborative and dedicated to building and leading talented and motivated individuals. Persistent leader eager to lead and grow organizations. Skilled in strategic planning, problem-solving, and communication with good understanding of business principles, project management and team leadership. Collaborative with relentless work ethic. Top-notch [Job Title] with proven track record of success leading and growing organizations. Strong background in strategic planning, financial management and team development. Skilled in identifying opportunities and implementing practical business strategies with commitment to staying informed about latest trends, technologies and best practices. Pursuing full-time role that presents professional challenges and leverages interpersonal skills, effective time management, and problem-solving expertise. Tech-savvy innovator with hands-on experience in emerging technologies and passion for continuous improvement. Skilled in identifying opportunities for technological enhancements and implementing effective solutions. Adept at leveraging new tools and methods to solve problems and enhance productivity. Excels in adapting to fast-paced environments and driving technological advancements.

Overview

23
23
years of professional experience

Work History

Founder & Principal

Telesmar, LLC
Seattle Area, WA
01.2024 - Current
  • Challenge: Create research and commercial strategies with prioritized tactics for clients in a rapidly changing public health policy and reimbursement landscape for genomic-based diagnostic tests, regulatory quality real-world data (RWD) & evidence (RWE)
  • Develops research and go-to-market strategies for clinical genomics laboratories & biotech clients, incorporating FDA and ASTP/ONC mandates and the Inflation Reduction Act (IRA)
  • Acts as external scientific advisor for a collaborative healthIT initiative with a large US Native American sovereign nation to ensure privacy and tribal control of health and scientific research data

Head, Medical Strategy, Ops & Advocacy, Global R&D

Pfizer, Inc.
New York
01.2023 - 01.2024
  • Challenge: Centralize all global, regional and country-level evidence strategy, execution, compliance, & partnership capabilities supporting cross-functional teams from molecule to marketplace to expedite approval & access, drive scientific excellence in >50 countries, and focus on high ROI public health activities
  • Executive sponsor for enterprise integrated evidence plans delineating strategies and tactics for prioritized evidence, AI/ML, and patient-facing digital solutions that aligns with corporate mission and priorities from early R&D through post-launch for >80 medicine, vaccine and gene therapy programs
  • Accelerated regulatory approvals by up to 20% & avoided >$3B in underperforming investments and unnecessary costs from data-driven decision-making
  • Chaired RWE protocol review and synthesized evidence summary (e.g., medical and marketing messages) approval committees to ensure methodological rigor, appropriate data source quality, and reproducibility
  • Served as a public-facing executive at conferences and helped shape global health equity policy through legislative, regulatory, Ministries of Health and other federal authorities
  • Expanded team to >225 Manager- to VP-level colleagues across the globe, supporting all therapeutic areas and their programs with $250M annual OpEx/year, while saving 30% cost base and publishing >75 peer-reviewed papers

VP & Head of Evidence Generation, Global CMO

Pfizer, Inc.
New York
01.2021 - 01.2023
  • Challenge: Overcome silos in a highly matrixed organization, optimize ROI, & translate global policies/regulations and other headwinds/tailwinds into actionable strategies, prioritized tactics, & evidence to impact >1 billion patients
  • Grew R&D-, BD- and commercial-empowering RWE platform and capabilities to >110 FTEs to power ~750 studies and projects per year including, but not limited to regulatory hybrid RWE-interventional trials & persuasive payer evidence
  • Directed team to manage >100 tech, healthIT & RWD partnerships including innovative sources such as wastewater monitoring & near real-time electronic prescription/prior authorization tracking
  • Led team to publish >100 papers in peer-reviewed journals & generate landmark evidence for COVID vaccine & PAXLOVID emergency use authorizations, adding 9 years of total US & EU exclusivity and peak sales of $8-12B/year, etc.
  • Recognized global scientific leader - myriad invited talks, 1 of 3 projects selected by FDA for their Advancing Real-World Evidence Program’s inaugural call, papers referenced by FDA Commissioner & used as teaching tool in advanced degree & certification programs

VP, RWE Center of Excellence, Global Biopharma

Pfizer, Inc.
New York
01.2020 - 01.2021
  • Challenge: Stand up an entirely new capabilities, systems and evidence infrastructure to generate faster benefits to patients, accelerate medicines & vaccines to market, and improve quality care within global health systems across the entire product portfolio & lifecycle
  • Grew team from n-of-1 to ~50 FTEs in under one year with >30 peer-reviewed manuscripts while establishing processes to prioritize on-mission studies and ensure evidence quality for regulatory, health economic, health equity and other purposes
  • Identified issue with healthcare sites’ EHR prior authorization (ePA) code that would have cost company estimated $15B in sales per year from drug switches caused by false ePA rejections. Collaborated with field force to help resolve sites’ issues.
  • Served as a public face for Pfizer RWE. Initiated the CARE Initiative with Aetion, pharma sponsors, clinical oncologists, and myriad RWD companies to recapitulate oncology trials with RWE to bolster provider confidence

Senior Director, RWE & Data Lead, Access & HEOR

Pfizer, Inc.
New York
01.2018 - 01.2020
  • Challenge: Transition franchise teams from a risk-averse culture of “no” to accept & adapt to innovative new approaches to tackle business challenges
  • Created Pfizer's first comprehensive RWE aspiration, strategy, & resourcing model to support Oncology's 23 medicines, optimizing processes by 200%
  • Founder & Chair of the Oncology Engine and RWE Lead for all Oncology franchises, including landmark RWE-based label enhancement for palbociclib, adding male patients with metastatic breast cancer to label
  • Led the RWE conversation in podcasts, invitation-only regulatory workshops, invited platform talks, & global RWE initiatives (eg, IMI2’s EHDEN & H2O, Komen Big Data 4 Breast Cancer)

Vice President, Data, Strategy and Innovation

CDISC
Austin
01.2016 - 01.2018
  • Challenge: Served as chief scientist & strategist, Board interface, and fund-raiser ($4M, 50% of total budget) of global non-profit that develops clinical and translational research standards required for regulatory submissions
  • Executive leader of Blue Ribbon Commission co-chaired by FDA Commissioner with regulators, industry, Gates Foundation, Wellcome Trust, etc. members to shape CDISC's future. Ensured on-time completion of last mile activities post-tenure.
  • Created strategy for CDISC's collaborative community of >450 global academic, industry, non-profit, patient groups & tech companies while developing standards to speed research for breast cancer, prostate cancer, malaria, TB, HIV, and other diseases
  • Participated in quarterly Board meetings & gained endorsement for myriad strategic initiatives & innovation opportunities (eg, rebranding, automation, grant writing)

Director, Biomedical Informatics Shared Resource

Baylor College of Medicine
Houston
01.2011 - 01.2016
  • Challenge: Create robust health and biomedical informatics and engineering infrastructure to improve patient outcomes & advance scientific frontiers
  • Transformed fragmented ecosystem of >50 different databases to a suite of end-to-end products & services for omics, biobank, registry, EHR and claims data powering ~$200M annual projects across >10 hospital systems & affiliates
  • Led “academic CRO” biometrics, data management & RBM for >350 phase I-III interventional & non-interventional trials

Assistant Professor

Baylor College of Medicine
Houston
01.2009 - 01.2016
  • Challenge: Lead cutting-edge interdisciplinary projects and train the next generation of scientists
  • Collaborated with hospitalists, Human Genome Sequencing Center, bioethicists, statisticians, and other colleagues on >150 high risk/high reward projects in Oncology, Molecular Tumor Boards, Endocrinology, Immunology and Reproductive Health

Subject Matter Expert (SME)

NIH and FDA
Washington DC
01.2003 - 01.2018
  • Contract SME for NIH (NCI, NIDDK, NHLBI) and FDA, & Study Section member (NIDDK, NHLBI)

Education

Ph.D. - Health Informatics and Clinical & Translational Microbiology

Baylor College of Medicine
Houston, TX
01.2008

B.S. Summa Cum Laude - Dual - Clinical Microbiology And Molecular Biology

Mississippi State University
Starkville, MS
01.2003

Skills

  • Health & Research Data
  • Analytics & AI
  • Executive leadership
  • Team development & growth
  • Strategic planning & execution
  • Entrepreneurial and innovative
  • Client engagement
  • Partnership building

Awards

  • Kavli Fellow of the National Academy of Sciences
  • W.M. Keck Fellow of the Gulf Coast Consortia
  • NIH Roadmap Fellow
  • NCI caBIG Fellow
  • Pfizer Saxon R&D Award
  • Pfizer Digital Breakthrough Award
  • Pfizer Game Changer Award
  • Komen Faculty & various board memberships

Timeline

Founder & Principal

Telesmar, LLC
01.2024 - Current

Head, Medical Strategy, Ops & Advocacy, Global R&D

Pfizer, Inc.
01.2023 - 01.2024

VP & Head of Evidence Generation, Global CMO

Pfizer, Inc.
01.2021 - 01.2023

VP, RWE Center of Excellence, Global Biopharma

Pfizer, Inc.
01.2020 - 01.2021

Senior Director, RWE & Data Lead, Access & HEOR

Pfizer, Inc.
01.2018 - 01.2020

Vice President, Data, Strategy and Innovation

CDISC
01.2016 - 01.2018

Director, Biomedical Informatics Shared Resource

Baylor College of Medicine
01.2011 - 01.2016

Assistant Professor

Baylor College of Medicine
01.2009 - 01.2016

Subject Matter Expert (SME)

NIH and FDA
01.2003 - 01.2018

Ph.D. - Health Informatics and Clinical & Translational Microbiology

Baylor College of Medicine

B.S. Summa Cum Laude - Dual - Clinical Microbiology And Molecular Biology

Mississippi State University